Concord, MA, United States of America

David Andrew Sandham

This inventor holds 2 USPTO granted patents and 3 published patent applications. Top assignee: Novartis Ag. Active years: 2023-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: David Andrew Sandham. Retrieved from https://idiyas.com/inventor/david-andrew-sandham-6t6sxhc3

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 2 

% Patents Active = 100.0

Average Co-Inventor Count = 15.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2023-2024

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Spotlight on Inventor David Andrew Sandham

Introduction

David Andrew Sandham, based in Concord, MA, is an accomplished inventor with a focus on pharmaceutical innovations. He has made significant contributions to the field, holding a total of two patents that showcase his expertise and creativity in drug development.

Latest Patents

Sandham's latest patents include groundbreaking work on Heteroaryl substituted spiropiperidinyl derivatives and their pharmaceutical applications. The key invention provides a compound of a specific formula, or a pharmaceutically acceptable salt thereof, with defined characteristics that facilitate the method for manufacturing these compounds. Furthermore, these patents also detail their therapeutic uses, offering a combination of pharmacologically active agents and a comprehensive pharmaceutical composition.

Career Highlights

David Andrew Sandham is associated with Novartis AG, a leading company in the healthcare sector known for its innovation and commitment to improving patient outcomes. His work within this esteemed organization has allowed him to develop vital pharmaceutical solutions that contribute to advancements in healthcare.

Collaborations

Throughout his career, Sandham has collaborated with notable professionals such as Mallesh Bushaboina and Xin Chen. These collaborations not only enhance the depth of his research but also enable the fusion of diverse expertise that drives innovation in pharmaceutical development.

Conclusion

David Andrew Sandham exemplifies the spirit of innovation in the pharmaceutical industry. With his valuable patents and collaborative endeavors, he firmly establishes himself as a vital contributor to the development of novel therapeutic agents. His work continues to pave the way for advancements that may greatly benefit patients in need of effective treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…